GlassScriptPhysician profile
Emily C Culbert
NPI 1528181625
$850.11
in general payments reported to CMS, 2019-2025
14 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $91.28 · 2021: $83.89 · 2022: $132 · 2023: $157 · 2024: $107 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.64 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $215.46 | 2019-2024 | Liletta |
| Coopersurgical, INC. | $110.69 | 2019-2023 | Mara Console, Paragard T 380a |
| Merck Sharp & Dohme LLC | $98.59 | 2019-2021 | |
| Pfizer INC. | $90.62 | 2019-2022 | |
| Hologic Sales and Service, LLC | $69.95 | 2024-2025 | Thinprep 2000 Processor |
| Organon LLC | $58.59 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $50.00 | 2024 | |
| Becton, Dickinson and Company | $32.53 | 2021-2022 | |
| Exeltis, USA INC. | $24.50 | 2025 | Slynd |
| Exact Sciences Corporation | $23.55 | 2025 | The Cologuard Plus Collection Kit |
| Evofem Biosciences, INC. | $21.52 | 2022 | |
| Dexcom, INC. | $20.92 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $17.81 | 2021 | |
| Janssen Biotech, INC. | $15.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Culbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.